Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Créteil
Clinical trial register · France

Clinical Trials in Créteil, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Créteil 14 Clermont-Ferrand 12 Avignon 11 Dijon 11 Bordeaux 10
Narrow the registerReset
Recruitment status
Phase
Site location
Créteil14 Clermont-Ferrand12 Avignon11 Dijon11 Bordeaux10
All 33 locations
Target enrolment
to

Trials with a site in Créteil

14 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
NCT07814001Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Refractory Large B-cell Lymphoma (LBCL), Refractory T-cell/Histiocyte-rich Large B-cell Lymphoma, Refractory Transformed Follicular Lymphoma
The Lymphoma Academic Research Organisation
Phase 2
55
Créteil, Dijon, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes
2026-12
Not yet open
The Lymphoma Academic Research Organisation
Observational
129
Amiens, Angers, Avignon, Besançon, Clermont-Ferrand, Créteil, Dijon, La Roche-sur-Yon
2026-06-30
Recruiting
Glofitamab in Real Life
NCT06994169Large B-cell Lymphoma
The Lymphoma Academic Research Organisation
Observational
250
Argenteuil, Avignon, Bayonne, Besançon, Clamart, Créteil, Dijon, Dunkirk
2025-12-01
Recruiting
The Lymphoma Academic Research Organisation
Phase 1/2
49
Caen, Clermont-Ferrand, Créteil, Dijon, La Tronche, Le Mans, Lille, Marseille
2025-08-20
Recruiting
The Lymphoma Academic Research Organisation
Phase 2
100
Créteil, Dijon, Lille, Marseille, Montpellier, Nantes, Pierre-Bénite, Reims
2025-02-21
Recruiting
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
NCT06271057Diffuse Large B-cell Lymphoma Refractory, Refractory Primary Mediastinal Large B-Cell Lymphoma, Refractory Transformed B-cell Non-Hodgkin Lymphoma, Refractory High Grade B-Cell Lymphoma
The Lymphoma Academic Research Organisation
Phase 2
65
Créteil, Dijon, La Tronche, Lille, Marseille, Montpellier, Nantes, Paris
2024-06-14
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Avignon, Bayonne, Besançon, Bordeaux, Cahors, Chambéry, Clermont-Ferrand, Créteil
2024-06-07
Recruiting
The Lymphoma Academic Research Organisation
Phase 3
260
Nancy, Amiens, Avignon, Bayonne, Besançon, Bordeaux, Clermont-Ferrand, Créteil
2023-09-05
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
210
Angers, Avignon, Bayonne, Besançon, Brest, Caen, Clermont-Ferrand, Créteil
2022-01-24
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
141
Avignon, Bayonne, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon
2021-06-11
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
62
Bordeaux, Clermont-Ferrand, Créteil, Dijon, Lille, Montpellier, Nantes, Paris
2021-03-10
Recruiting
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
NCT04328298Hematopathology Eligible or CAR-t Cell Treatment
The Lymphoma Academic Research Organisation
Observational
5,000
Amiens, Angers, Besançon, Brest, Caen, Clermont-Ferrand, Créteil, Dijon
2019-12-19
Recruiting
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
NCT04220970Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
The Lymphoma Academic Research Organisation
Observational
150
Avignon, Bordeaux, Brest, Colmar, Créteil, Dijon, Lille, Lyon
2017-06-07
Active, closed
The Lymphoma Academic Research Organisation
Phase 1/2
214
Clermont-Ferrand, Argenteuil, Avignon, Besançon, Bordeaux, Chambéry, Créteil, Dijon
2016-10
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 October 2026. https://priyalifescience.com/clinical-trials-france/city/cr-teil

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Créteil that also match the filters currently applied.

How many clinical trials are recruiting in Créteil?

7 of the 14 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 2 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Créteil), 14 studies
PhaseStudiesRecruitingShare
Phase 26242.9%
Observational4328.6%
Phase 1/22114.3%
Phase 32114.3%

Most active sponsors

Lead sponsors with the most studies (Créteil)
Lead sponsorStudiesRecruiting
The Lymphoma Academic Research Organisation147
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.